Jemperli
JEMPERLI is a medicine that may treat certain cancers by working with your immune system, including a kind of uterine cancer called endometrial cancer (EC) and a kind of cancer that is shown by laboratory test to be dMMR solid tumor.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
![](https://vivoinfusion.com/wp-content/uploads/2024/07/download.png)
MANUFACTURER: GlaxoSmithKline LLC |
CLASS: Monoclonal antibody |
WHAT IT TREATS: Certain types of cancer |
PRESCRIBED BY:
|
HOW ADMINISTERED: Intravenous Infusion |
FREQUENCY: Every 3 weeks for 6 doses, then every 6 weeks.
|
Length of infusion: 30 mins |
FOR MORE INFORMATION: |